Redefining Hormone Sensitive Disease in Advanced Prostate Cancer

Por Hou, Xiaoyu, Flaig, Thomas W.
Publicado em 2012

Re: Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status

Por Flaig, Thomas W., Theodorescu, Dan
Publicado em 2012

The dawn of personalized medicine

Por Flaig, Thomas W., Theodorescu, Dan
Publicado em 2011

Geriatric considerations in the treatment of advanced prostate cancer

Por Kessler, Elizabeth R., Flaig, Thomas W.
Publicado em 2014

Review of SWOG S1314: Lessons from a Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer

Por Boxley, Peter, Plets, Melissa, Flaig, Thomas W.
Publicado no Bladder Cancer (2020)

Pazopanib synergizes with docetaxel in the treatment of bladder cancer cells

Por Li, Yuan, Yang, Xiaoping, Su, Lih-Jen, Flaig, Thomas W.
Publicado em 2011

Low-dose diethylstilbestrol for the treatment of advanced prostate cancer

Por Clemons, Julia, Glodé, L. Michael, Gao, Dexiang, Flaig, Thomas W.
Publicado em 2011

miR-125b Regulation of Androgen Receptor Signaling Via Modulation of the Receptor Complex Co-Repressor NCOR2

Por Yang, Xiaoping, Bemis, Lynne, Su, Lih-Jen, Gao, Dexiang, Flaig, Thomas W.
Publicado em 2012

Renal cell carcinoma: a review of biology and pathophysiology

Por Nabi, Shahzaib, Kessler, Elizabeth R., Bernard, Brandon, Flaig, Thomas W., Lam, Elaine T.
Publicado no F1000Res (2018)

Thyroid Dysfunction in Patients Treated With Sunitinib or Sorafenib

Por Clemons, Julia, Gao, Dexiang, Naam, Mary, Breaker, Kathryn, Garfield, David, Flaig, Thomas W.
Publicado em 2012

Treatment evolution for metastatic castration‐resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real‐world data

Por Flaig, Thomas W., Potluri, Ravi C., Ng, Yvette, Todd, Mary B., Mehra, Maneesha
Publicado no Cancer Med (2015)

Silibinin suppresses CD44 expression in prostate cancer cells

Por Handorean, Alina M., Yang, Kui, Robbins, Eric W., Flaig, Thomas W., Iczkowski, Kenneth A.
Publicado em 2009

Clinical significance of sunitinib‐associated macrocytosis in metastatic renal cell carcinoma

Por Bourlon, Maria T., Gao, Dexiang, Trigero, Sara, Clemons, Julia E., Breaker, Kathryn, Lam, Elaine T., Flaig, Thomas W.
Publicado no Cancer Med (2016)

Multifunctional Nanoclusters of NaYF(4): Yb(3+),Er(3+) Upconversion Nanoparticle and Gold Nanorod for Simultaneous Imaging and Targeted Chemotherapy of Bladder Cancer

Por Cho, Suehyun K., Su, Lih-Jen, Mao, Chenchen, Wolenski, Connor D., Flaig, Thomas W., Park, Wounjhang
Publicado no Mater Sci Eng C Mater Biol Appl (2018)

Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction

Por Flaig, Thomas W., Plets, Melissa, Hussain, Maha H. A., Agarwal, Neeraj, Mitsiades, Nicholas, Deshpande, Hari A., Vaishampayan, Ulka N., Thompson, Ian M.
Publicado no JAMA Oncol (2017)

The detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma

Por Flaig, Thomas W., Wilson, Shandra, van Bokhoven, Adrie, Varella-Garcia, Marileila, Wolfe, Pamela, Maroni, Paul, Genova, E. Erin, Morales, Diana, Lucia, M. Scott
Publicado em 2011

Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT)

Por Altoos, Basel, Amini, Arya, Yacoub, Muthanna, Bourlon, Maria T., Kessler, Elizabeth E., Flaig, Thomas W., Fisher, Christine M., Kavanagh, Brian D., Lam, Elaine T., Karam, Sana D.
Publicado no Radiat Oncol (2015)

The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer Model

Por Yang, Xiaoping, Su, Lih-Jen, La Rosa, Francisco G., Smith, Elizabeth Erin, Schlaepfer, Isabel R., Cho, Suehyun K., Kavanagh, Brian, Park, Wounjhang, Flaig, Thomas W.
Publicado no Bladder Cancer (2017)

Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium

Por Flaig, Thomas W., Kamat, Ashish M., Hansel, Donna, Ingersoll, Molly A., Barton Grossman, H., Mendelsohn, Cathy, DeGraff, David, Liao, Joseph C., Taylor, John A.
Publicado no Bladder Cancer (2017)

Local control rates of metastatic renal cell carcinoma to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?′

Por Amini, Arya, Altoos, Basel, Bourlon, Maria T., Bedrick, Edward, Bhatia, Shilpa, Kessler, Elizabeth R., Flaig, Thomas W., Fisher, Christine M., Kavanagh, Brian D, Lam, Elaine T., Karam, Sana D.
Publicado no Pract Radiat Oncol (2015)